Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Non-cash Items (2019 - 2023)

Historic Non-cash Items for Vivos Therapeutics (VVOS) over the last 5 years, with Q2 2023 value amounting to $100000.0.

  • Vivos Therapeutics' Non-cash Items fell 9525.84% to $100000.0 in Q2 2023 from the same period last year, while for Jun 2023 it was $100000.0, marking a year-over-year decrease of 9525.84%. This contributed to the annual value of $65.5 million for FY2022, which is N/A changed from last year.
  • Per Vivos Therapeutics' latest filing, its Non-cash Items stood at $100000.0 for Q2 2023, which was down 9525.84% from $65.5 million recorded in Q4 2022.
  • In the past 5 years, Vivos Therapeutics' Non-cash Items registered a high of $65.5 million during Q4 2022, and its lowest value of $100000.0 during Q2 2023.
  • For the 5-year period, Vivos Therapeutics' Non-cash Items averaged around $7.5 million, with its median value being $2.1 million (2022).
  • As far as peak fluctuations go, Vivos Therapeutics' Non-cash Items soared by 4743.81% in 2021, and later plummeted by 9525.84% in 2023.
  • Over the past 5 years, Vivos Therapeutics' Non-cash Items (Quarter) stood at $6.7 million in 2019, then crashed by 53.7% to $3.1 million in 2020, then tumbled by 36.99% to $2.0 million in 2021, then soared by 3253.07% to $65.5 million in 2022, then plummeted by 99.85% to $100000.0 in 2023.
  • Its last three reported values are $100000.0 in Q2 2023, $65.5 million for Q4 2022, and $2.2 million during Q3 2022.